1. Bosanquet AG (1991) Correlations between therapeutic response of leukaemias and in-vitro drug-sensitivity assay. Lancet 337:711–714
2. Delmer A, Marie J-P, Thevenin D, Cadiou M, Viguié F, Zittoun R (1989) Multivariate analysis of prognostic factors in acute myeloid leukemia: value of clonogenic leukemic cell properties. J Clin Oncol 7:738–746
3. Dörffel W, Hartmann R, Schober S, Veerman AJP, Pieters R, Klumper E, Henze G (1993) Drug resistance testing as a basis for tailored therapy in children with refractory or relapsed acute lymphoblastic leukemia. In: Kaspers GJL, Pieters R, Twentyman PR, Weisenthal LM, Veerman AJP (eds) Drug resistance in leukemia and lymphoma. The clinical value of laboratory assays. Harwood Academic, London, pp 353–358
4. Gazdar A, Steinberg SM, Russell (1990) Correlation of in vitro drug-sensitivity testing results with response to chemotherapy and survival in extensive small cell lung cancer. A prospective clinical trial. J Natl Cancer Inst 82:117–124
5. Gustavsson A, Olofsson T (1984) Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells. Cancer Res 44:4648–4652